Sabino Strippoli

Sabino Strippoli

UNVERIFIED PROFILE

Are you Sabino Strippoli?   Register this Author

Register author
Sabino Strippoli

Sabino Strippoli

Publications by authors named "Sabino Strippoli"

Are you Sabino Strippoli?   Register this Author

19Publications

-Reads

Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

BMC Cancer 2016 11 18;16(1):905. Epub 2016 Nov 18.

Functional Biomorphology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124, Bari, Italy.

View Article
November 2016

Ocular Toxicity in Metastatic Melanoma Patients Treated With Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series.

Am J Ophthalmol 2015 Nov 29;160(5):959-967.e1. Epub 2015 Jul 29.

Department of Medical Oncology, National Cancer Research Centre "Giovanni Paolo II", Bari, Italy.

View Article
November 2015

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report.

Oncol Lett 2015 Jun 14;9(6):2567-2571. Epub 2015 Apr 14.

Department of Medical Oncology, National Cancer Research Centre 'Giovanni Paolo II', Bari 70124, Italy.

View Article
June 2015

Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy.

J Transl Med 2015 Jan 27;13:26. Epub 2015 Jan 27.

Clinical and Preclinical Pharmacology Laboratory, National Cancer Research Centre Istituto Tumori Giovanni Paolo II, Viale O. Flacco,65, 70124, Bari, Italy.

View Article
January 2015

Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?

Exp Cell Res 2014 Feb 31;321(2):240-7. Epub 2013 Dec 31.

Medical Oncology Unit, National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Viale O. Flacco, 65, 70124 Bari, Italy.

View Article
February 2014

Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.

BMC Complement Altern Med 2013 Jul 30;13:199. Epub 2013 Jul 30.

Medical Oncology Department, National Cancer Research Centre Giovanni Paolo II, Bari, Italy.

View Article
July 2013

Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?

Oncologist 2011 9;16(7):1040-8. Epub 2011 Jun 9.

IMO, Department of Internal Medicine and Clinical Oncology, University of Bari, Aldo Moro, Italy.

View Article
January 2012

Cell fusion and hyperactive osteoclastogenesis in multiple myeloma.

Adv Exp Med Biol 2011 ;714:113-28

Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, 70124, Bari, Italy.

View Article
July 2011

Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.

Exp Hematol 2011 Jul 25;39(7):773-83.e1. Epub 2011 Apr 25.

DIMO, Department of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy.

View Article
July 2011

[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease].

Recenti Prog Med 2011 Feb;102(2):88-95

Dipartimento di Medicina Interna e Oncologia, Università, Bari.

View Article
February 2011

Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

J Biomed Biotechnol 2010 29;2010:457146. Epub 2010 Jun 29.

DIMO, Department of Internal Medicine and Clinical Oncology, University of Bari, Piazza Giulio Cesare 11, 70124 Bari, Italy.

View Article
January 2011

Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review.

Ann N Y Acad Sci 2009 Sep;1173:449-57

Department of Internal Medicine and Clinical Oncology, University of Bari, Bari, Italy.

View Article
September 2009